MR-130A-01
MR-130A-01-TD-2002
Phase 2 small_molecule active
Quick answer
MR-130A-01 for Investigation of maintenance of ovulation inhibition after intentional application errors for indication of contraception in healthy subjects is a Phase 2 program (small_molecule) at Mylan dura GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mylan dura GmbH
- Indication
- Investigation of maintenance of ovulation inhibition after intentional application errors for indication of contraception in healthy subjects
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active